Close Menu

    Subscribe to Updates

    Get the latest information from JBUON.

    What's Hot

    Two Cases of Pancreatic Metastases from Renal Cell Carcinoma and Review of the Literature

    April 17, 2025

    Exploration of Matrix Metalloproteinase-9 and Interleukin-8 in Breast Cancer Patients with No Lymph Node Involvement

    March 14, 2025

    Surgical Treatment of Right Atrial Metastasis of the Malignant Melanoma: A Case Report

    March 6, 2025
    Facebook X (Twitter) Instagram
    JBUONJBUON
    • How to Submit
    • Author Guidelines
    Facebook X (Twitter) Instagram
    SUBMIT
    • Home
    • Browse Issues
      • In Press
      • Current Issue
      • Archives
    • About Journal
      • Journal Information
      • Editorial Board
      • Bibliographic Listings
      • Editorial Policy
      • Ethics and Malpractice Statement
    • For Authors
      • How To Submit
      • Submit Article
      • Downloads
    • Contact
    JBUONJBUON
    Home»Issues»Volume 26, Issue 6»Radioactive iodine treatment planning for differentiated thyroid carcinoma: Comparison of different machine learning classification models
    Volume 26, Issue 6

    Radioactive iodine treatment planning for differentiated thyroid carcinoma: Comparison of different machine learning classification models

    November 30, 2021Updated:April 29, 20242 Mins Read
    Share
    Facebook Twitter Email

    Marina Popovic1, Dragana Sobic Saranovic2,3, Milos Nikolic4, Dusan Teodorovic4,5, Ivan Markovic2,6, Ljiljana Mijatovic Teodorovic1,7

    1Department of Nuclear Medicine, Institute for Oncology and Radiology of Serbia, Belgrade, Serbia.

    2University of Belgrade, School of Medicine, Belgrade, Serbia.

    3Center for Nuclear Medicine, Clinical Center of Serbia, Belgrade, Serbia.

    4University of Belgrade, Faculty of Transport and Traffic Engineering, Belgrade, Serbia.

    5Serbian Academy of Sciences and Arts, Belgrade, Serbia.

    6Surgical Oncology Clinic, Institute for Oncology and Radiology of Serbia, Belgrade, Serbia.

    7University of Kragujevac, Faculty of Medical Sciences, Kragujevac, Serbia.

    Summary

    Purpose: Radioactive iodine therapy (RAIT) is important when treating patients who have been diagnosed with differentiated thyroid carcinoma and have gone through initial surgery. However, deciding whether a patient should undergo such therapy as well as the proper iodine dose is a complex task, especially for those with a lack of experience. Therein, this paper aimed to develop and compare classifier systems to aid inexperienced physicians in decision making on radioactive iodine therapy for thyroid cancer patients.

    Methods: The study cohort consisted of 210 thyroid cancer patients who had undergone a total thyroidectomy. We developed and evaluated the performance of three machine learning (ML) algorithms that suggest whether these patients should undergo RAIT and propose an administrable I-131 dose. These algorithms were Artificial Neural Network (ANN), Naïve Bayes Classifier (NB) and Group Method of Data Handling (GMDH). The kappa coefficient was used to measure agreement of classifiers with gold standard decision made by an experienced physician.

    Results: Our results indicate that the ANN performs better than NB and GMDH in terms of accuracy (95.71%). On the basis of the Kappa coefficient, ANN was also the best 0.96 (0.91-1.00). Additionally, kappa coefficient increased to 0.93 (0.86-1.00) by comparing young physicians’ decisions on thyroid cancer therapy before and after using ANN as a decision making tool.

    Conclusion: Our results suggest that developed classifiers are able to imitate the real decisions of medical expert. Furthermore, classifiers may be utilized to educate inexperienced medical professionals, especially in the absence of strict guidelines’ recommendations.

    Key words: machine learning, radioactive iodine, thyroid cancer.

    Full Text: PDF

    Original Article
    Previous ArticleA new protocol of desensitization for systemic therapy agents in oncology
    Next Article The prognostic impact of ABO blood groups and Rhesus factor in patients with upper tract urothelial carcinoma

    Related Articles

    Exploration of Matrix Metalloproteinase-9 and Interleukin-8 in Breast Cancer Patients with No Lymph Node Involvement

    Volume 27, 2024

    Malignant Diseases as a Reason for Interventions by Emergency Medical Teams in Barajevo 2023

    Volume 27, 2024

    MicroRNA signatures landscape in renal cell carcinoma – related epithelial to mesenchymal transition

    Volume 26, Issue 6
    Don't Miss
    Volume 27, 2024

    Two Cases of Pancreatic Metastases from Renal Cell Carcinoma and Review of the Literature

    April 17, 2025

    Dimosthenis Chrysikos1, Spiros Delis2, Charina Triantopoulou2, Evgenia Charitaki2, Nikos Kokoroskos2, Nikolaos Taprantzis1*, Amir Shihada1, Konstantinos…

    Exploration of Matrix Metalloproteinase-9 and Interleukin-8 in Breast Cancer Patients with No Lymph Node Involvement

    March 14, 2025

    Surgical Treatment of Right Atrial Metastasis of the Malignant Melanoma: A Case Report

    March 6, 2025

    Abdominal Aortic Aneurysm and Radiation Therapy

    October 28, 2024
    Our Picks

    MicroRNA signatures landscape in renal cell carcinoma – related epithelial to mesenchymal transition

    December 1, 2021

    Chromosomal instability landscape in uveal melanoma

    December 1, 2021

    Biomarkers and common oral cancers: Clinical trial studies

    December 1, 2021

    Subscribe to Updates

    About Us
    About Us

    Journal of BUON (Print ISSN: 1107-0625, Electronic ISSN: 2241-6293) is an independent Open Access Journal, published by BAKIS Productions LTD, and appears exclusively on the internet. It is covered/indexed in Current Awareness in Biological Sciences (BIO-BASE), EMBASE/Excerpta Medica.
    We're accepting new manuscripts right now.

    Email Us: editorial_office@jbuon.com
    Contact: Available soon

    Editorial Picks

    MicroRNA signatures landscape in renal cell carcinoma – related epithelial to mesenchymal transition

    December 1, 2021

    Chromosomal instability landscape in uveal melanoma

    December 1, 2021

    Biomarkers and common oral cancers: Clinical trial studies

    December 1, 2021
    Get in Touch

    Editor-in-Chief
    Athanasios E. Athanasiou,
    Department of Medical Oncology,
    Metaxa Cancer Hospital, Botassi 51, 18537, Piraeus, Greece
    Editorial Office: editorial_office@jbuon.com

    Publishing support
    EManuscript Technologies
    # 9, First Floor, Vinnse Towers
    Wheeler Road Extension, St. Thomas Town, Bangalore 560 084, INDIA
    E: journals@emanuscript.in 
    W : www.emanuscript.in

     

    • Home
    • Author Guidelines
    • Site Map
    • Contact Us
    © 2025 JBUON Powered by EManuscript.

    Type above and press Enter to search. Press Esc to cancel.